Brain Cancer

News Brain Cancer

• The Ben & Catherine Ivy Foundation contributes $10 million to TGen for brain cancer research

  The Ben & Catherine Ivy Foundation has awarded $10 million in grants for two brain cancer research projects at the Translational Genomics Research Institute (TGen).One $five-million-project is titled "Outliers in Glioblastoma Outcome: Moving the curve forward." This five-year investigation seeks to more

• e-Therapeutics’ ETS2101 enters phase I clinical trial in brain cancer

  e-Therapeutics plc announces the start of the first clinical trial evaluating its compound ETS2101 as a treatment for cancer. The phase I trial is enrolling patients with primary brain cancer (glioma) or cancer that has spread to the brain from other sites. Led by Professor Santosh Kesari, MD, PhD, more

• Novel compound halts tumor spread, improves brain cancer treatment in animal studies
  

  Treating invasive brain tumors with a combination of chemotherapy and radiation has improved clinical outcomes, but few patients survive longer than two years after diagnosis. The effectiveness of the treatment is limited by the tumor's aggressive invasion of healthy brain tissue, which restricts ch more

Publications Brain Cancer

• Clinical and molecular models of Glioblastoma multiforme survival

  Clinical and molecular models of Glioblastoma multiforme survivalStephen R. Piccolo; Lewis J. FreyInternational Journal of Data Mining and Bioinformatics, Vol. 7, No. 3 (2013) pp. 245 - 265Glioblastoma multiforme (GBM), a highly aggressive form of brain cancer, results in a median survival of 12-15 more

• Low‐Dose Dexamethasone Treatment Promotes Pro‐Survival Signalling Pathway In Adult Rat Prefrontal Cortex

  Abstract Synthetic glucocorticoid dexamethasone (DEX), a highly potent anti‐inflammatory and immunosuppressive agent, is widely used in treatments of brain cancer, inflammatory and autoimmune diseases. The objective of the current study was to determine whether a low‐dose subchronic DEX treatmen more

• Interstitial Flow in a 3D Microenvironment Increases Glioma Invasion by a CXCR4-Dependent Mechanism

  Brain tumor invasion leads to recurrence and resistance to treatment. Glioma cells invade in distinct patterns, possibly determined by microenvironmental cues including chemokines, structural heterogeneity, and fluid flow. We hypothesized that flow originating from pressure differentials between the more

Market studies Brain Cancer

• Brain Cancer – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Brain Cancer - Pipeline Review, H2 2012', provides an overview of the Brain Cancer therapeutic pipeline. This report provides information on the therapeutic development for Brain Cancer, complete with latest updates, and special features on late-stage and dis more

• Brain Cancer – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Brain Cancer - Pipeline Review, H1 2012', provides an overview of the Brain Cancer therapeutic pipeline. This report provides information on the therapeutic development for Brain Cancer, complete with latest updates, and special features on late-stage and disc more

• United Kingdom Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: While the strength of the UK’s pharmaceutical manufacturing industry is significant, the sector will face considerable challenges over the coming years. Economic weakness, patent expirations and cost-containment with regard to public sector spending will negatively affect the country’s att more

Websites Brain Cancer